Your browser doesn't support javascript.
loading
Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
Müller-Thomas, Catharina; Rudelius, Martina; Rondak, Ina-Christine; Haferlach, Torsten; Schanz, Julie; Huberle, Christina; Schmidt, Burkhard; Blaser, Rainer; Kremer, Marcus; Peschel, Christian; Germing, Ulrich; Platzbecker, Uwe; Götze, Katharina.
Afiliação
  • Müller-Thomas C; III. Department of Medicine, Technical University of Munich, Munich.
  • Rudelius M; Institute of Pathology, Julius-Maximilians-University Würzburg, Munich.
  • Rondak IC; Institute for Medical Statistics and Epidemiology, Technical University of Munich, Munich.
  • Haferlach T; MLL, Munich Leukemia Laboratory, Munich.
  • Schanz J; Department of Hematology and Oncology, Georg-August-University Göttingen, Munich.
  • Huberle C; III. Department of Medicine, Technical University of Munich, Munich.
  • Schmidt B; Hematology and Oncology Pasing, Munich.
  • Blaser R; Institute for Medical Statistics and Epidemiology, Technical University of Munich, Munich.
  • Kremer M; Institute of Pathology Harlaching, Munich.
  • Peschel C; III. Department of Medicine, Technical University of Munich, Munich German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg.
  • Germing U; Department of Hematology and Oncology, Heinrich-Heine-University Düsseldorfand.
  • Platzbecker U; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg I. Department of Medicine, Gustav-Carus-University Dresden, Dresden, Germany.
  • Götze K; III. Department of Medicine, Technical University of Munich, Munich German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg k.goetze@lrz.tum.de.
Haematologica ; 99(10): e179-81, 2014 Oct.
Article em En | MEDLINE | ID: mdl-24972774

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Antimetabólitos Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Antimetabólitos Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article